Bulls vs Bears
Click to unlock major analysts' bullish and bearish positions by joining Benzinga Edge.
Click to unlock major analysts' bullish and bearish positions by joining Benzinga Edge.
Arteris Inc has a consensus price target of $12.14 based on the ratings of 7 analysts. The high is $17 issued by Wedbush on February 20, 2024. The low is $7 issued by BMO Capital on November 9, 2022. The 3 most-recent analyst ratings were released by Northland Capital Markets, Rosenblatt, and Rosenblatt on February 19, 2025, February 19, 2025, and February 18, 2025, respectively. With an average price target of $15.33 between Northland Capital Markets, Rosenblatt, and Rosenblatt, there's an implied 86.99% upside for Arteris Inc from these most-recent analyst ratings.
1calculated from analyst ratings
The latest price target for Arteris (NASDAQ:AIP) was reported by Northland Capital Markets on February 19, 2025. The analyst firm set a price target for $16.00 expecting AIP to rise to within 12 months (a possible 95.12% upside). 9 analyst firms have reported ratings in the last year.
The latest analyst rating for Arteris (NASDAQ:AIP) was provided by Northland Capital Markets, and Arteris maintained their outperform rating.
There is no last upgrade for Arteris
The last downgrade for Arteris Inc happened on May 13, 2024 when Jefferies changed their price target from $11 to $9 for Arteris Inc.
Analysts arrive at stock ratings after doing extensive research, which includes going through public financial statements, talking to executives and customers of Arteris, and listening in to earnings conference calls. Most analysts do this every three months, so you should get 4 ratings per company per firm each year. The last rating for Arteris was filed on February 19, 2025 so you should expect the next rating to be made available sometime around February 19, 2026.
While ratings are subjective and will change, the latest Arteris (AIP) rating was a maintained with a price target of $14.00 to $16.00. The current price Arteris (AIP) is trading at is $8.20, which is out of the analyst’s predicted range.
Browse analyst ratings and price targets on all stocks.